Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: Relationship with nutritional status, cyanosis and left ventricular functions

Neuroendocrinology Letters

Volumn 28, Issue 3, 2007, Pages 279-283

  Dinleyici, Ener Cagri ^a   Kilic, Zubeyir ^a   Buyukkaragoz, Bahar ^a   Ucar, Birsen ^a   Alatas, Ozkan ^a   Aydogdu, Sultan D ^a   Dogruel, Nesrin ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Congenital heart disease; IGF 1; IGFBP 3; Left ventricular function; Malnutrition

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CHILD; CHILD NUTRITION; CHILDHOOD DISEASE; CHRONIC DISEASE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYANOSIS; FEMALE; GROWTH HORMONE DEFICIENCY; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HUMAN; HYPOXIA; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; RISK FACTOR;

EID: 34447256832     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Roodpeyma S, Kamali Z, Afshar F, Naraghi S. Risk factors in congenital heart disease. Clin Pediatr. 2002; 41: 653-8.
2. Krieger I. Growth failure and congenital heart disease: energy and nitrogen balance in infants. AJDC. 1970; 120: 497-504.
3. Menon G, Poskitt EME. Why does congenital heart disease cause failure to thrive? Arch Dis Child. 1985; 60: 1134-39.
4. Soliman AT, Madkour A, Galil MA, El Zalabany M, Aziz SM, Ansari BM. Growth parameters and endocrine function in relation to echocardiographic parameters in children with ventricular septal defect without heart failure. J Trop Pediatr. 2001; 47: 146-52.
5. Varan B, Tokel K, Yilmaz G. Malnutrition and growth failure in cyanotic and acyanotic congenital heart disease with and without pulmonary hypertension. Arch Dis Child. 1999; 81: 49-52.
6. Soliman AT, ElZalabany MM, Salama M, Ansari BM. Serum leptin concentrations during severe protein-energy malnutrition: correlation with growth parameters and endocrine function. Metabolism. 2000; 49: 819-25.
7. Bentham J, Rodriguez-Arnao J, Ross RJM. Acquired growth hormone resistance in patients with hypercatabolism. Horm Res. 1993; 40: 87-91.
8. Barton JS, Hindmarsh PC, Preece MA. Serum insulin-like growth factor in congenital heart disease. Arch Dis Child. 1996; 75: 162-3.
9. Leitch CA, Karn CA, Peppard RJ, Granger D, Liechty EA, Ensing GJ, et al. Increased energy expenditure in infants with cyanotic congenital heart disease. J Pediatr. 1998; 133: 755-60.
10. Dinleyici EC, Tekin N, Colak O, Aksit MA. Serum IGF-1 and IGFBP-3 levels in asphyxiated term newborns. Neuro Endocrinol Lett. 2006; 27: 745-7.
11. Bernstein D, Jasper JR, Rosenfold RG, Hintz RL. Decreased serum insulin-like growth factor 1 associated with growth failure in newborn lambs with experimental cyanotic heart disease. J Clin Invest. 1992; 89: 1128-32.
12. Dundar B, Akcoral A, Saylam G, Unal N, Mese T, Hudaoglu S, et al. Chronic hypoxmia leads to reduced serum IGF-1 levels in cyanotic congenital heart disease. J Pediatr Endocr Met. 2000; 13: 431-6.
13. Ikkos DD, Thanapoulos V, Ikkos DG. 24h plasma levels of growth hormone in growth retardation of children with congenital heart disease. Helv Pediatr Acta. 1974; 29: 583-8.
14. Fahrer M, Gruneiro L, Rivarola M, Bergada C. Levels of plasma growth hormone in children with congenital heart disease. Acta Endcorinol (Copenh). 1974; 77: 451-9.
15. Argente J, Barrios V, Pozo J, Munoz MT, Hervas F, Stene M, et al. Normative data for insulin-like growth factors, IGF binding proteins and growth hormone binding protein in a healthy Spanish population: age and sex related changes. J Clin Endcorinol Met. 1993; 77: 1522-8.
16. Rosenfeld RG. Disorders of growth hormone and insulin-like growth factor secretion and action. In: Sperling MA (ed). Pediatric Endocrinology. Philadelphia, WB Saunders Company. 1996; 117-69.
17. Feinberg MS, Scheinowitz M, Laron Z. Echocaridographic dimensions and functions in adults with primary growth hormone resistance (Laron syndrome). Am J Cardiol. 2000; 85: 209-13.